Almanack Investment Partners’s Johnson & Johnson JNJ Stock Holding History

Almanack Investment Partners’s Portfolio JNJ Stock Details JNJ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$4.39M	Buy	17,302 +3,418	+25%	+$797K	0.56%	35
2026 Q1	$3.39M	Sell	13,884 -57	-0.4%	-$13.3K	0.57%	20
2025 Q4	$2.89M	Buy	13,941 +867	+7%	+$171K	0.49%	29
2025 Q3	$2.42M	Buy	13,074 +2,985	+30%	+$511K	0.37%	40
2025 Q2	$1.54M	Buy	10,089 +3,456	+52%	+$531K	0.25%	63
2025 Q1	$1.1M	Buy	6,633 +71	+1%	+$11.1K	0.22%	54
2024 Q4	$949K	Sell	6,562 -96	-1%	-$14.9K	0.15%	77
2024 Q3	$1.08M	Buy	6,658 +166	+3%	+$26.4K	0.17%	70
2024 Q2	$949K	Buy	6,492 +62	+1%	+$9.22K	0.16%	77
2024 Q1	$1.02M	Buy	6,430 +80	+1%	+$12.7K	0.17%	73
2023 Q4	$995K	Sell	6,350 -396	-6%	-$60.7K	0.18%	63
2023 Q3	$1.05M	Sell	6,746 -1,240	-16%	-$205K	0.2%	58
2023 Q2	$1.32M	Sell	7,986 -43	-0.5%	-$6.94K	0.23%	53
2023 Q1	$1.24M	Buy	8,029 +3,145	+64%	+$508K	0.25%	52
2022 Q4	$863K	Sell	4,884 -6,492	-57%	-$1.12M	0.18%	63
2022 Q3	$1.86M	Buy	11,376 +238	+2%	+$40.3K	0.36%	35
2022 Q2	$1.98M	Sell	11,138 -1,206	-10%	-$215K	0.2%	78
2022 Q1	$2.19M	Sell	12,344 -628	-5%	-$107K	0.19%	83
2021 Q4	$2.22M	Sell	12,972 -298	-2%	-$48.8K	0.18%	84
2021 Q3	$2.14M	Buy	13,270 +1,122	+9%	+$191K	0.19%	83
2021 Q2	$2M	Sell	12,148 -1,089	-8%	-$180K	0.19%	80
2021 Q1	$2.18M	Buy	13,237 +679	+5%	+$110K	0.22%	75
2020 Q4	$1.98M	Buy	12,558 +1,605	+15%	+$237K	0.23%	65
2020 Q3	$1.62M	Buy	10,953 +1,656	+18%	+$245K	0.2%	67
2020 Q2	$1.31M	Buy	9,297 +2,548	+38%	+$371K	0.23%	51
2020 Q1	$885K	Buy	6,749 +2,673	+66%	+$379K	0.19%	68
2019 Q4	$595K	Sell	4,076 -6	-0.1%	-$814	0.11%	94
2019 Q3	$528K	Sell	4,082 -70	-2%	-$9.22K	0.1%	113
2019 Q2	$578K	Buy	4,152 +1,662	+67%	+$230K	0.13%	84
2019 Q1	$348K	Sell	2,490 -2,004	-45%	-$268K	0.1%	94
2018 Q4	$580K	Sell	4,494 -73	-2%	-$10.2K	0.17%	70
2018 Q3	$661K	Buy	4,567 +990	+28%	+$132K	0.17%	70
2018 Q2	$434K	Sell	3,577 -351	-9%	-$43.8K	0.2%	48
2018 Q1	$503K	Buy	3,928 +881	+29%	+$119K	0.19%	44
2017 Q4	$426K	Buy	3,047 +256	+9%	+$35.7K	0.17%	65
2017 Q3	$363K	Buy	2,791 +330	+13%	+$43.7K	0.18%	60
2017 Q2	$326K	Buy	2,461 +853	+53%	+$109K	0.18%	81
2017 Q1	$200K	Sell	1,608 -873	-35%	-$104K	0.15%	101
2016 Q4	$286K	Buy	+2,481	New	+$287K	0.24%	49

Other funds holding JNJ

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

State Farm Mutual Automobile Insurance Bloomington, Illinois $146B AUM 55.73% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Almanack Investment Partners's JNJ Position: Q2 2026 in Review

Almanack Investment Partners increased its Johnson & Johnson (JNJ) stake by 25% in Q2 2026, buying an estimated $797K and bringing the position to 17,302 shares worth $4.39M. The position accounts for 0.56% of the portfolio, ranked #35.

Almanack Investment Partners first reported a position in JNJ in Q4 2016 and has held it in 39 quarters since. 4,665 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

Almanack Investment Partners held 17,302 shares of Johnson & Johnson worth $4.39M as of Q2 2026.
Almanack Investment Partners bought 3,418 Johnson & Johnson shares in Q2 2026, an estimated $797K.
Johnson & Johnson made up 0.56% of Almanack Investment Partners's portfolio in Q2 2026, its #35 holding.
Almanack Investment Partners first reported a position in Johnson & Johnson in Q4 2016 and has held it in 39 quarters since.
4,665 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Almanack Investment Partners's 13F filing for Q2 2026, filed 30 Jul 2026.